Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Acquires Worldwide Exclusive License to Novel RNAi Platform Aug 25, 2011 Tekmira Acquires Worldwide Exclusive License to Novel RNAi Platform 21.3 KB Halo-Bio's Multivalent RNA Molecules Induce RNAi of Multiple Targets ... Read more Summary ToggleTekmira Provides Corporate Update and Announces Second Quarter 2011 Results Aug 11, 2011 Tekmira Provides Corporate Update and Announces Second Quarter 2011 Results 33.5 KB Conference Call at 12 pm Eastern Time Today ... Read more Summary ToggleTekmira Announces Additional Clinical Trial of TKM-PLK1 with the U.S. National Cancer Institute Aug 09, 2011 Tekmira Announces Additional Clinical Trial of TKM-PLK1 with the U.S. National Cancer Institute 21 KB FDA Approves Clinical Protocol for Additional Phase 1 Study of TKM-PLK1 ... Read more Summary ToggleTekmira Conference Call and Webcast Advisory: Second Quarter 2011 Operating Results and Corporate Update Aug 04, 2011 Tekmira Conference Call and Webcast Advisory: Second Quarter 2011 Operating Results and Corporate Update 14.5 KB ... Read more Summary ToggleTekmira Reports Expected Answer and Amended Counterclaim is Filed by Alnylam Jun 29, 2011 Tekmira Reports Expected Answer and Amended Counterclaim is Filed by Alnylam 18.7 KB ... Read more Summary ToggleTekmira Closes $5.1 Million Public Offering Jun 16, 2011 Tekmira Closes $5.1 Million Public Offering 17.2 KB ... Read more Summary ToggleTekmira Prices Public Offering Jun 09, 2011 Tekmira Prices Public Offering 17.9 KB ... Read more Summary ToggleTekmira Announces Proposed Public Offering Jun 08, 2011 Tekmira Announces Proposed Public Offering 17.1 KB ... Read more Summary ToggleTekmira's LNP Delivery Technology Enables Proof of RNAi in Man and Clinical Activity Jun 06, 2011 Tekmira's LNP Delivery Technology Enables Proof of RNAi in Man and Clinical Activity 22 KB Tekmira Comments on Phase I Clinical Data for ALN-VSP Presented at ASCO Meeting ... Read more Summary ToggleTekmira Files Amended Complaint in Alnylam Litigation Jun 03, 2011 Tekmira Files Amended Complaint in Alnylam Litigation 18.4 KB ... Read more Pagination First page First Previous page Previous … Page 39 Current page 40 Page 41 Page 42 … Next page Next Last page Last Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Acquires Worldwide Exclusive License to Novel RNAi Platform Aug 25, 2011 Tekmira Acquires Worldwide Exclusive License to Novel RNAi Platform 21.3 KB Halo-Bio's Multivalent RNA Molecules Induce RNAi of Multiple Targets ... Read more Summary ToggleTekmira Provides Corporate Update and Announces Second Quarter 2011 Results Aug 11, 2011 Tekmira Provides Corporate Update and Announces Second Quarter 2011 Results 33.5 KB Conference Call at 12 pm Eastern Time Today ... Read more Summary ToggleTekmira Announces Additional Clinical Trial of TKM-PLK1 with the U.S. National Cancer Institute Aug 09, 2011 Tekmira Announces Additional Clinical Trial of TKM-PLK1 with the U.S. National Cancer Institute 21 KB FDA Approves Clinical Protocol for Additional Phase 1 Study of TKM-PLK1 ... Read more Summary ToggleTekmira Conference Call and Webcast Advisory: Second Quarter 2011 Operating Results and Corporate Update Aug 04, 2011 Tekmira Conference Call and Webcast Advisory: Second Quarter 2011 Operating Results and Corporate Update 14.5 KB ... Read more Summary ToggleTekmira Reports Expected Answer and Amended Counterclaim is Filed by Alnylam Jun 29, 2011 Tekmira Reports Expected Answer and Amended Counterclaim is Filed by Alnylam 18.7 KB ... Read more Summary ToggleTekmira Closes $5.1 Million Public Offering Jun 16, 2011 Tekmira Closes $5.1 Million Public Offering 17.2 KB ... Read more Summary ToggleTekmira Prices Public Offering Jun 09, 2011 Tekmira Prices Public Offering 17.9 KB ... Read more Summary ToggleTekmira Announces Proposed Public Offering Jun 08, 2011 Tekmira Announces Proposed Public Offering 17.1 KB ... Read more Summary ToggleTekmira's LNP Delivery Technology Enables Proof of RNAi in Man and Clinical Activity Jun 06, 2011 Tekmira's LNP Delivery Technology Enables Proof of RNAi in Man and Clinical Activity 22 KB Tekmira Comments on Phase I Clinical Data for ALN-VSP Presented at ASCO Meeting ... Read more Summary ToggleTekmira Files Amended Complaint in Alnylam Litigation Jun 03, 2011 Tekmira Files Amended Complaint in Alnylam Litigation 18.4 KB ... Read more Pagination First page First Previous page Previous … Page 39 Current page 40 Page 41 Page 42 … Next page Next Last page Last
Tekmira Announces Additional Clinical Trial of TKM-PLK1 with the U.S. National Cancer Institute 21 KB
Tekmira Conference Call and Webcast Advisory: Second Quarter 2011 Operating Results and Corporate Update 14.5 KB